Omega Healthcare Investors (OHI) Cost of Revenue (2009 - 2011)

Omega Healthcare Investors has disclosed Cost of Revenue across 3 years of filings, most recently posting $50000.0 for Q4 2011.

• Cost of Revenue for Q4 2011 came in at $50000.0, down 66.44% year-over-year; the trailing twelve-month figure through Dec 2011 was $653000.0 (down 91.84% YoY), and the FY2011 annual result was $653000.0, down 91.84% from the prior year.
• Cost of Revenue came in at $50000.0 for Q4 2011 at Omega Healthcare Investors, down from $148000.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $5.5 million in Q2 2009 to a low of $50000.0 in Q4 2011.
• The 3-year median for Cost of Revenue is $480000.0 (2010), against an average of $2.2 million.
• Peak annual rise in Cost of Revenue reached 49.13% in 2010, while the deepest fall reached 96.95% in 2010.
• Omega Healthcare Investors' Cost of Revenue stood at $4.9 million in 2009, then slumped by 96.95% to $149000.0 in 2010, then slumped by 66.44% to $50000.0 in 2011.
• The last three Cost of Revenue figures came in at $50000.0 (Q4 2011), $148000.0 (Q3 2011), and $225000.0 (Q2 2011), per Business Quant data.